rs185863881

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_153006.3(NAGS):​c.374C>A​(p.Thr125Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0034 in 1,569,814 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T125P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0036 ( 12 hom. )

Consequence

NAGS
NM_153006.3 missense

Scores

2
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:7O:1

Conservation

PhyloP100: 1.25

Publications

6 publications found
Variant links:
Genes affected
NAGS (HGNC:17996): (N-acetylglutamate synthase) The N-acetylglutamate synthase gene encodes a mitochondrial enzyme that catalyzes the formation of N-acetylglutamate (NAG) from glutamate and acetyl coenzyme-A. NAG is a cofactor of carbamyl phosphate synthetase I (CPSI), the first enzyme of the urea cycle in mammals. This gene may regulate ureagenesis by altering NAG availability and, thereby, CPSI activity. Deficiencies in N-acetylglutamate synthase have been associated with hyperammonemia. [provided by RefSeq, Jul 2008]
NAGS Gene-Disease associations (from GenCC):
  • hyperammonemia due to N-acetylglutamate synthase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007922173).
BP6
Variant 17-44005037-C-A is Benign according to our data. Variant chr17-44005037-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 377250.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00196 (299/152354) while in subpopulation SAS AF = 0.00517 (25/4834). AF 95% confidence interval is 0.00359. There are 0 homozygotes in GnomAd4. There are 121 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 12 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_153006.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NAGS
NM_153006.3
MANE Select
c.374C>Ap.Thr125Lys
missense
Exon 1 of 7NP_694551.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NAGS
ENST00000293404.8
TSL:1 MANE Select
c.374C>Ap.Thr125Lys
missense
Exon 1 of 7ENSP00000293404.2
NAGS
ENST00000589767.1
TSL:2
c.281C>Ap.Thr94Lys
missense
Exon 1 of 7ENSP00000465408.1

Frequencies

GnomAD3 genomes
AF:
0.00196
AC:
299
AN:
152238
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000675
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00190
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00517
Gnomad FIN
AF:
0.000565
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00300
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00272
AC:
480
AN:
176178
AF XY:
0.00318
show subpopulations
Gnomad AFR exome
AF:
0.000417
Gnomad AMR exome
AF:
0.00222
Gnomad ASJ exome
AF:
0.00218
Gnomad EAS exome
AF:
0.000142
Gnomad FIN exome
AF:
0.000101
Gnomad NFE exome
AF:
0.00276
Gnomad OTH exome
AF:
0.00271
GnomAD4 exome
AF:
0.00355
AC:
5033
AN:
1417460
Hom.:
12
Cov.:
31
AF XY:
0.00372
AC XY:
2613
AN XY:
702376
show subpopulations
African (AFR)
AF:
0.000671
AC:
22
AN:
32764
American (AMR)
AF:
0.00237
AC:
95
AN:
40054
Ashkenazi Jewish (ASJ)
AF:
0.00102
AC:
26
AN:
25480
East Asian (EAS)
AF:
0.0000796
AC:
3
AN:
37698
South Asian (SAS)
AF:
0.00724
AC:
590
AN:
81532
European-Finnish (FIN)
AF:
0.000249
AC:
10
AN:
40098
Middle Eastern (MID)
AF:
0.00157
AC:
9
AN:
5736
European-Non Finnish (NFE)
AF:
0.00371
AC:
4066
AN:
1095098
Other (OTH)
AF:
0.00359
AC:
212
AN:
59000
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
312
624
936
1248
1560
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
172
344
516
688
860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00196
AC:
299
AN:
152354
Hom.:
0
Cov.:
32
AF XY:
0.00162
AC XY:
121
AN XY:
74504
show subpopulations
African (AFR)
AF:
0.000673
AC:
28
AN:
41584
American (AMR)
AF:
0.00189
AC:
29
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00517
AC:
25
AN:
4834
European-Finnish (FIN)
AF:
0.000565
AC:
6
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00300
AC:
204
AN:
68028
Other (OTH)
AF:
0.00142
AC:
3
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
18
35
53
70
88
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00247
Hom.:
2
Bravo
AF:
0.00213
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00337
AC:
13
ESP6500AA
AF:
0.000699
AC:
3
ESP6500EA
AF:
0.00202
AC:
17
ExAC
AF:
0.00182
AC:
216
Asia WGS
AF:
0.000867
AC:
3
AN:
3476

ClinVar

ClinVar submissions as Germline

Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
3
Hyperammonemia, type III (5)
-
-
2
not provided (2)
-
-
1
NAGS-related disorder (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.16
CADD
Benign
15
DANN
Benign
0.93
DEOGEN2
Benign
0.26
T
Eigen
Benign
-0.62
Eigen_PC
Benign
-0.54
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.68
T
MetaRNN
Benign
0.0079
T
MetaSVM
Benign
-0.42
T
MutationAssessor
Benign
0.90
L
PhyloP100
1.2
PrimateAI
Benign
0.34
T
PROVEAN
Benign
1.7
N
REVEL
Uncertain
0.35
Sift
Benign
1.0
T
Sift4G
Benign
0.76
T
Polyphen
0.36
B
Vest4
0.37
MVP
0.83
MPC
0.92
ClinPred
0.010
T
GERP RS
1.1
PromoterAI
-0.014
Neutral
Varity_R
0.052
gMVP
0.49
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs185863881; hg19: chr17-42082405; API